SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Reiber, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiber, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases

Hansotto Reiber

Neurochemisches Labor der Neurologischen Klinik, Universitat Göttingen, Germany

The state of the art in routine CSF analysis is reviewed with particular reference to multiple sclerosis regarding: (1) The physiology and pathophysiology of blood-CSF barrier function and dysfunction with the CSF flow rate as main modulator of blood- and brain-derived protein concentrations in CSF; (2) The neuroimmunological aspects regarding (a) patterns of disease-related immunoglobulin class response (IgG, lgA, IgM) in actual Reiber graphs with reference to specific parameters and optional tests, and (b) the oligoclonal, polyspecific antibody synthesis in brain; (3) Particular marker proteins in CSF and blood for differential diagnosis of neurological diseases; (4) Mathematical base for evaluations of CSF data with an example of a multiple sclerosis patient for calculation of intrathecal immunoglobulin and antibody synthesis as well as Antibody Index.

Key Words: cerebrospinal fluid • protein patterns • analysis • physiology • pathophysiology • blood-CSF barrier function • neuro immunology

Multiple Sclerosis, Vol. 4, No. 3, 99-107 (1998)
DOI: 10.1177/135245859800400302


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Jarius, D Franciotta, R Bergamaschi, S Rauer, K P Wandinger, H F Petereit, M Maurer, H Tumani, A Vincent, P Eichhorn, et al.
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1134 - 1136.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. A. Strauss, J. Lazovic, M. Wintermark, and D. H. Morton
Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency
Brain, July 1, 2007; 130(7): 1905 - 1920.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Cepok, B. Rosche, V. Grummel, F. Vogel, D. Zhou, J. Sayn, N. Sommer, H.-P. Hartung, and B. Hemmer
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
Brain, July 1, 2005; 128(7): 1667 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Bjorkhem
Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers
J. Lipid Res., April 1, 2003; 44(4): 793 - 799.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Marchi, V. Fazio, L. Cucullo, K. Kight, T. Masaryk, G. Barnett, M. Volgelbaum, M. Kinter, P. Rasmussen, M. R. Mayberg, et al.
Serum Transthyretin Monomer as a Possible Marker of Blood-to-CSF Barrier Disruption
J. Neurosci., March 1, 2003; 23(5): 1949 - 1955.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. M. Verbeek, H. P.M. de Reus, and C. W. Weykamp
Comparison of Methods for the Detection of Oligoclonal IgG Bands in Cerebrospinal Fluid and Serum: Results of the Dutch Quality Control Survey
Clin. Chem., September 1, 2002; 48(9): 1578 - 1580.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Richard, V. Miossec, J.-F. Moreau, and J.-L. Taupin
Detection of Oligoclonal Immunoglobulins in Cerebrospinal Fluid by an Immunofixation-Peroxidase Method
Clin. Chem., January 1, 2002; 48(1): 167 - 173.
[Abstract] [Full Text] [PDF]



Advertisement